Skip to content
MedsAcross

Brand family

Epivir

Lamivudine · ViiV Healthcare
European UnionUnited States
Presentations
3
Markets
2

Epivir is a brand of Lamivudine marketed by ViiV Healthcare, with 3 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Lamivudine
Brand owner
ViiV Healthcare
Registered in
European Union, United States
Strengths and forms
10 mg/mL oral solution, 150 mg tablet, 300 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Epivir 10 mg/mL oral solutionOralViiV HealthcareUS FDAAvailable on request
Epivir 150 mg tabletOralViiV HealthcareUS FDAAvailable on request
Epivir 300 mg tabletOralViiV HealthcareUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Epivir

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.